Business
Scottish Prostate Cancer Initiative
EDX Medical Group plc has been appointed as the primary delivery partner for the Scottish Prostate Cancer Initiative, a new project aimed at enhancing early detection and diagnosis of prostate cancer. This initiative will offer free Prostate-Specific Antigen (PSA) testing to 25,000 men aged 40 to 80 across Scotland throughout the year, utilizing blood samples for analysis. The project will also deploy advanced diagnostic tests for selected groups to investigate genetic risk factors and other biochemical markers associated with prostate cancer, with the goal of improving the existing clinical pathway. A pilot program successfully tested over 1400 men in the West of Scotland in February and March. Disclaimer*
About this update from Edx Medical Group Plc
[{"type":"text","content":"\n\n\nMarch 25, 2026\nEDX Medical Group plc\nAQSE: EDX\n(\"EDX Medical\" or \"the Company\")\n \nScottish Prostate Cancer Initiative\nCAMBRIDGE, UK: EDX Medical Group plc, which develops innovative digital diagnostic products and services supporting personalised treatments for cancer, cardiovascular and infectious diseases, announces that the Company is to be the primary delivery partner in the Scottish Prostate Cancer Initiative, a new project which aims to improve the early detection and diagnosis of the disease.\nThe Initiative has been launched at the Royal Glasgow of Physicians and Surgeons in Glasgow by Olympian Sir Chris Hoy, Scottland rugby internationalist, Kenny Logan, Sir Tom Hunter and Professor Sir Chris Evans, founder of EDX Medical.\nMajor employers and organisations from various sectors are supporting the Initiative.\nThroughout this year, EDX Medical will provide diagnostic tests and laboratory services to the Initiative which will offer 25,000 men across Scotland aged between 40 and 80 free PSA testing.\nEach man who participates in the Initiative will be asked to give a simple blood sample to measure Prostate-Specific Antigen (PSA) levels. In addition, a range of more advanced diagnostic tests will be deployed across selected groups of men to help develop a greater understanding of the role of genetic risk and the significance of other biochemical markers in the origins of prostate cancer.\nThe aim of the study is to explore how the existing clinical pathway for detecting and treating prostate cancer can be improved.\nThe not-for-profit Initiative is supported by a range of organisations and employers across Scotland and findings from the study will be made available to NHS Scotland.\nOrganisations supporting the project include the Scottish Police Federation, Glasgow Credit Union and Dundee City Council. Employers include businessmen Sandy and James Easdale and McGill's Buses, The Arnold Clark Group, The Malcolm Group, Lord Haughey and City Facilities Management. Inverness Caledonian Thistle and St Johnstone Football Clubs will be hosting testing events at their stadiums.\nEDX Medical is delivering the Initiative in conjunction with the Graham Fulford Charitable Trust, a prostate health awareness charity. A pilot programme was completed in February and early March in the West of Scotland with the su...